News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer
Ovarian Cancer
Feb 1, 2025, 16:18

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared an article by Jeffrey Bell, et al. on X:

“Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian cancer:

GOG 157: 3 cycles of chemo may be sufficient for high risk early stage EOC.”

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study.

Authors: Jeffrey Bell, et al.

Randomized phase III trial of adjuvant carboplatin and paclitaxel in epithelial ovarian cancer

cancer carboplatin EOC fight against cancer Global fight against cancer MVR Cancer Centre and Research Institute OncoDaily Oncology Ovarian Cancer Paclitaxel
Special Coverage
Voices
Aug 10, 2025, 19:51
Herbert Loong: AP Lung Cancer Policy Consensus Presented at SOM3 Meeting
Voices
Aug 10, 2025, 15:36
Wafaa M Rashed: Africa for Africans - Shaping the Future of Genomics Policy
Career
Aug 10, 2025, 15:36
Bogda Koczwara: Join the Team of Australian Research Centre for Cancer Survivorship
Voices
Aug 10, 2025, 15:26
Sendurai Mani: Joining the Partnership to Reduce Cancer in Rhode Island Membership Meeting
Career
Aug 10, 2025, 15:00
Santosh Rao Joined to the HemOnc Department at Cleveland Clinic Akron General as the Medical Director
Science
Aug 10, 2025, 14:54
Monika J Dziuba: The Role of Organoids in Precision Medicine
Voices
Aug 10, 2025, 14:50
The Future of Pharmaceutical Infrastructure and Equitable Access to Medicines - Hikma Pharmaceuticals
Voices
Aug 10, 2025, 14:31
Anju Aledia: Celebrating Strength, Unity, and Hope Among Children Fighting Cancer
Voices
Aug 10, 2025, 14:19
Harish Nagaraj: Advancing Neuroendocrine Tumor Care in East and Sub-Saharan Africa
Opinion
Aug 10, 2025, 13:44
Olivier Elemento: Accelerating Innovation with Safe and Effective Guardrails
Voices
Aug 10, 2025, 13:01
Olubukola Ayodele: Breast Cancer Subtypes and What They Mean for Patients and Treatment
Voices
Aug 10, 2025, 12:49
Krishna Soujanya Gunturu: The Hartford HealthCare Cancer Institute Has Launched First-in-Human Phase 1A Clinical Trial